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The prediction of the risks of cancer and other late effects from space radiation exposure carries large 
uncertainties mostly due to the lack of information on the risks from high charge and energy (HZE) 
particles and other high linear energy transfer (LET) radiation. In our recent work new methods were 
used to consider NASA’s requirement to protect against the acceptable risk of no more than 3% probability 
of cancer fatality estimated at the 95% conﬁdence level. Because it is not possible that a zero-level of 
uncertainty could be achieved, we suggest that an acceptable uncertainty level should be deﬁned in 
relationship to a probability distribution function (PDF) that only suffers from modest skewness with 
higher uncertainty allowed for a normal PDF. In this paper, we evaluate PDFs and the number or “safe 
days” in space, which are deﬁned as the mission length where risk limits are not exceeded, for several 
mission scenarios at different acceptable levels of uncertainty. In addition, we brieﬂy discuss several 
important issues in risk assessment including non-cancer effects, the distinct tumor spectra and lethality 
found in animal experiments for HZE particles compared to background or low LET radiation associated 
tumors, and the possibility of non-targeted effects (NTE) modifying low dose responses and increasing 
relative biological effectiveness (RBE) factors for tumor induction. Each of these issues skew uncertainty 
distributions to higher fatality probabilities with the potential to increase central values of risk estimates 
in the future. Therefore they will require signiﬁcant research efforts to support space exploration within 
acceptable levels of risk and uncertainty.
© 2015 The Committee on Space Research (COSPAR). Published by Elsevier Ltd. This is an open access 
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Space radiation protection methods are derived largely from 
ground based methods recommended by the National Council on 
Radiation Protection and Measurements (NCRP) (NCRP, 1993) or 
International Commission on Radiological Protections (ICRP) (ICRP, 
1990). Radiation protection is built on the principles of risk justi-
ﬁcation, limitation and ALARA (As Low As Reasonably Achievable). 
However because of the large uncertainties in HZE particle radiobi-
ology and the small population of space workers, distinct methods 
are used at NASA to implement a radiation protection program. 
The basic approach is derived from recommendations by the NCRP 
(NCRP, 1989, 2000, 2014), however in a series of developments 
over the last 15 years methods to implement uncertainty analysis 
have been developed, undergone external review by the National 
Research Council (NRC) (NRC, 2008, 2012), NCRP (NCRP, 2014) and 
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).through peer-review publications (Cucinotta et al., 2001, 2006, 
2013a, 2013b; Cucinotta, 2014, 2015), and implemented by NASA. 
Future focus on uncertainty reduction in risk predictions is consid-
ered in this paper.
In our recent work (Cucinotta et al., 2013b; Cucinotta, 2014, 
2015) several methods were introduced and shown to reduce over-
all space mission risk predictions or uncertainties: 1) particle track 
structure concepts were used to formulate a space radiation quality 
factor (QF) function that is dependent on particle charge number, 
Z and kinetic energy per atomic mass unit, E with QF uncertainties 
where represented by subjective probability distribution functions 
(PDF), 2) A QF model was formulated, denoted QFγAcute with QFs 
deﬁned relative to acute γ -ray doses (0.5 to 3 Gy) based on RBE 
and dose and dose-rate effectiveness factor (DDREF) data for solid 
tumors in several strains of mice, 3) Distinct QFs for solid can-
cers and leukemia risk were introduced with lower values for the 
latter, and 4) a never-smoker population model was introduced 
to represent astronauts and shown to reduce risks by about 30% 
compared to the U.S. Average population. Other results showed 
possible increases in space radiation risks including: 1) additional td. This is an open access article under the CC BY-NC-ND license 
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fects (Cucinotta et al., 2013a, 2014), 2) the potential of increased 
tumor lethality for high LET particles (Cucinotta, 2014, 2015), and 
3) the distinct mechanisms and dose response from non-targeted 
effects (NTE) that may alter low dose and chronic irradiation pre-
diction. In this paper, we consider the number of safe days in space 
where risks and uncertainties are below NASA’s limits in light of 
these recent developments.
In addition an important issue that has not been discussed in 
detail is the deﬁnition of an acceptable level of uncertainty (ALU). 
Without this deﬁnition safety programs could be burdened by un-
realistic expectations on the accuracy of risk projections. The focus 
of the current paper is to consider the ultimate outcome of such 
research, whereby reaching a zero level of uncertainty (ZLU) is 
deemed not possible, and the deﬁnition of an ALU becomes crucial. 
The current approach is to consider the 95% conﬁdence interval 
(CI) which is consistent with biomedical research standards on sig-
niﬁcance. However, NASA’s Strategic Plan for Radiation Research 
from 1998 (Strategic, 1998) deﬁned a 50% uncertainty level as the 
goal of research. In this paper we compared different methods to 
test risk predictions with their current levels of uncertainty. We 
suggest that the ideal case is a risk estimate that has all three 
of the following three attributes: 1) a central estimate below the 
REID limit, 2) an overall PDF for the REID prediction that follows 
a normal distribution in shape, and 3) the 95% conﬁdence level 
of the PDF is no more than 50% above the REID limit. In this ap-
proach the radiobiological factors that cause the large skewness 
observed in current risk predictions to higher REID values are the 
main issue to be addressed by research studies. We consider var-
ious deﬁnitions of an acceptable uncertainty level in relationship 
to the number of “safe days” in space (deﬁned as days to reach 
exposure limits) for typical shielding amounts for GCR exposure 
at a deep solar minimum (taken as the 2009 space environment) 
and for the average solar modulation of GCR using our recently 
published NASA Space Cancer Risk, NSCR-2014 model (Cucinotta, 
2014, 2015), which is an update of our earlier NSCR-2012 model 
(Cucinotta et al., 2013a). Finally, we brieﬂy review the major issues 
that make the current estimates highly skewed towards unaccept-
able REID values.
2. Methods
We brieﬂy summarize recent methods developed to predict the 
risk of exposure induced death (REID) for space missions and as-
sociated uncertainty distributions (Cucinotta et al., 2013a, 2013b; 
Cucinotta, 2014, 2015). The instantaneous cancer incidence or mor-
tality rates, λI and λM , respectively, are modeled as functions of 
the tissue averaged absorbed dose DT , or dose-rate DTr , gender, 
age at exposure aE , and attained age a or latency L, which is the 
time after exposure L = a − aE . The λI (or λM ) is a sum over rates 
for each tissue that contributes to cancer risk, λIT (or λMT ). These 
dependencies vary for each cancer type that could be increased 
by radiation exposure. The total risk of exposure induced cancer 
(REIC) is calculated by folding the instantaneous radiation cancer 
incidence-rate with the probability of surviving to time t , which 
is given by the survival function S0(t) for the background popu-
lation times the probability for radiation cancer death at previous 
time, summing over one or more space mission exposures, and 
then integrating over the remainder of a lifetime (United Nations 
Scientiﬁc Committee on the Effects of Atomic Radiation, 2008):
REIC(aE , DT ) =
Nm∑
j=1
∫
aE j
dtλI j(aE j , t, DT j)S0(t)
× e−
∑Nm
k=1
∫ t
aE
dzλMk (aEk ,z,DTk) (1)where z is the dummy integration variable. In Eq. (1), Nm is the 
number of missions (exposures), and for each exposure, j, there 
is a minimum latency of 5-years for solid cancers, and 2-years 
for leukemia assumed. Tissue speciﬁc REIC estimates are similar 
to Eq. (1) using the single term from λI of interest. The equation 
for REID estimates is similar to Eq. (1) with the incidence rate re-
placed by the mortality rate (deﬁned below).
The tissue-speciﬁc cancer incidence rate for an organ absorbed 
dose, DT , is written as a weighted average of the multiplicative 
and additive transfer models, denoted as a mixture model after 
adjustment for low dose and dose-rates through introduction of 
the dose and dose-rate effectiveness factor (DDREF) and radiation 
quality through the space radiation QF:
λIT(aE ,a, HT ) =
[
vT ERRT (aE ,a)λ0IT(a) + (1− vT )EART (aE ,a)
]
× QF • DT
DDREF
(2)
where vT is the tissue-speciﬁc transfer model weight, λ0IT is the 
tissue-speciﬁc cancer incidence rate in the reference population, 
and where ERRT and EART are the tissue speciﬁc excess relative 
risk and excess additive risk per Sievert, respectively. The tissue 
speciﬁc rates for cancer mortality λMT are modeled following the 
BEIR VII report (BEIR VII, 2006) whereby the incidence rate of 
Eq. (2) is scaled by the age, sex, and tissue speciﬁc ratio of rates 
for mortality to incidence in the population under study:
λMT(aE ,a, HT ) = λ0MT(a)
λ0IT(a)
λIT(aE ,a, HT ) (3)
The U.S. cancer rates from 2011 as represented by the DEVCAN 
software (Version 6.7.2) available from the Center of Disease Con-
trol (CDC) are used in this report (DevCan, 2014). DEVCAN provides 
age, sex and tissue speciﬁc incidence and mortality data to ages 
95+. Corrections for never-smokers for cancer and circulatory risks 
were made as described previously (Cucinotta et al., 2013a, 2012).
Risks of circulatory diseases were made in the same manner 
as our previous reports (Cucinotta et al., 2013b; Cucinotta, 2014). 
Circulatory disease risks included cardiovascular disease (CVD) and 
ischemic heart disease (IHD) using excess relative risk (ERR) esti-
mates from a recent meta-analysis of studies of atomic bomb sur-
vivors, and nuclear workers in several countries (Little et al., 2012). 
Circulatory disease risk estimates were made using the dose equiv-
alent for the blood forming system (BFO) based on the distinct 
deterministic effects relative biological effectiveness (RBE) factor 
compared (NCRP, 2000) to that of cancer estimates, and with-
out the use of a dose and dose-rate reduction effectiveness factor 
(DDREF) because the meta-analysis is based largely on chronic ex-
posures. For circulatory disease risks because the RBE is distinct 
from the quality factor (QF), organ dose equivalents are expressed 
in terms of a different unit, Gray-Equivalent (Gy-Eq) (NCRP, 2000).
The QF function divided by the DDREF is modeled as being 
made-up of two terms in the NSCR-2012 model (Cucinotta, 2015):
QF(Z , E)
DDREF
= Q low(Z , E) + Qhigh(Z , E)
DDREF
(4)
In Eq. (4) Qhigh and Q low roughly represent the contributions 
from a particle track acting in high density (track core) or low den-
sity modes (track penumbra), respectively with the radiosensitivity 
parameters described below deﬁning these relative contributions. 
Parameters are estimated from available RBEmax data for mouse 
tumor induction or surrogate endpoints in cell culture models as 
described previously (Cucinotta et al., 2013a).
The NSCR-2014 model QF makes an assessment of QFs based on 
RBEs determined from low dose and dose-rate particle data rela-
tive to acute γ -ray from experiments for doses of about 0.5 to 3 Gy 
denoted as RBEγAcute which was suggested by Edwards (1999). 
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Parameters for central estimate of NASA quality factor (QF) parameters for solid 
cancer and leukemia risks (Cucinotta et al., 2013a) in NSCR-2012 and NSCR-2014.a
Parameter Solid Cancer Leukemia
m 3 3
κ 550 (1000) 550 (1000)
Σ0/αγ , μm2 Gy (NSCR-2012) 7000/6.24 1750/6.24
Σ0/αγ , μm2 Gy (NSCR-2014) 2700/6.24 1750/6.24
ETD MeV/u 0.15 0.15
a Values in parenthesis are distinct values for light ions (Z ≤ 4). Values of m, κ , 
and ETD are identical in NSCR-2012 and NSCR-2014.
This approach alleviates the need to consider low dose-rate γ -ray 
experiments for RBE estimates, however for low LET particles a 
DDREF is still warranted because of their expected reduced effec-
tiveness at low dose-rates compared to acute γ -ray exposures at 
higher doses. The QF is then written:
QFγAcute(Z , E)
DDREF
= Q low(Z , E)
DDREF
+ Q¯ high(Z , E) (5)
where Q¯ high uses a parameter estimate for Σ0/αγ based on esti-
mates of RBEγAcute as described above instead of RBEmax. The key 
assumption of the model given by Eq. (5) is that the low ionization 
density part of a particle track is inﬂuenced by dose-rate effects as 
represented by the ﬁrst term on the right hand side of Eq. (5), 
while the high ionization density part of a particles track has no 
dependence on dose-rate as described by the second term on the 
right-hand side of Eq. (5). A DDREF is needed for the low ioniza-
tion density particles or track regions because risk model param-
eters are largely derived from data at higher dose and dose-rates 
than occur in space. The QF function shape parameters, m and κ
are taken as the same as in the NSCR-2012 model (Cucinotta et al., 
2013a) (Table 1) with the QF functions deﬁned as:
Q low(Z , E) =
(
1− P (Z , E)) (6)
and
Qhigh(Z , E) = (Σ0/αγ )P (Z , E)LET (7)
where the ratio Σ0/αγ is used as a single parameter, and the func-
tion originating in the parametric model of Katz et al. (1971) is 
given by,
P (Z , E) = (1− e−Z∗2/κβ2)m(1− e−E/ETD) (8)
The second product in Eq. (8) represents a so-called thin-down 
correction for low energy particles (E < 1 MeV/u) (Cucinotta et 
al., 2013a). The space radiation QF depends on two physical pa-
rameters: particle charge number, Z and kinetic energy per atomic 
mass unit, E . However, a key parameter that describes the den-
sity of a particle track is Z∗2/β2, where Z∗ is the effective charge 
number of a particle, which includes a velocity-dependent screen-
ing correction at low energies, and β is the particle velocity scaled 
to the speed of light, and is used to simplify the description of QF 
(Cucinotta et al., 2013a).
In NSCR-2012 and NSCR-2014 distinct quality factors for es-
timating solid cancer and leukemia risk are used (Cucinotta et 
al., 2013a; Cucinotta, 2015). A DDREF is not used in Eq. (2) for 
leukemia risk estimates and instead the linear component of a 
linear-quadratic dose response model ﬁt to human γ -ray epidemi-
ology data is used.
The HZETRN code (Cucinotta et al., 2013a; Wilson et al., 1994)
with quantum fragmentation model (QMSFRG) cross sections 
(Cucinotta et al., 2007) and a recent version of the Badhwar–O’Neill 
GCR environment (reviewed in Cucinotta et al., 2013a) are used to 
estimate organ doses and particle spectra as described previously (Cucinotta et al., 2013a). These methods agree with spaceﬂight 
data in low Earth orbit, in transit to Mars and on the Mars surface 
to within 15% for dose and dose equivalent (Cucinotta et al., 2013a;
Kim et al., 2014; ICRP, 2013). For the application of the model 
to space mission predictions the energy spectra for each parti-
cle type, j of LET, L j(E) for each tissue, T contributing to cancer 
risk denoted as φ jT (E) is estimated from radiation transport codes 
(Cucinotta et al., 2013a; Cucinotta, 2015). The particle energy spec-
tra are folded with the QF and DDREF factors described above 
to estimate tissue speciﬁc or total REID values (Cucinotta et al., 
2013a; Cucinotta, 2015).
We estimated the effects of higher tumor lethality for HZE par-
ticles and neutrons in the following manner. An upper limit on 
the possibility of higher tumor lethality would be to use REIC esti-
mates for REID estimates on space missions. However this estimate 
would be too large due to the presence of low LET particles such 
as protons that make up a signiﬁcant fraction of space radiation or-
gan doses or the low density part of HZE particle tracks which are 
a low LET radiation. To make a more realistic estimate of the ef-
fects of an increased lethality the cancer mortality rate is modiﬁed 
as (Cucinotta, 2014, 2015)
λMT ≈ λ0MT(a)
λ0IT(a)
λIγ T
{∑
j
∫
dEφ jT (E)L j(E)
(
1− P (Xtr)
)
+ (Σ0/αγ )Flethal
∫
dXtrφT (Xtr)P (Xtr)
}
(9)
The ﬁrst term in Eq. (9) dominates for low LET radiation and is 
not altered under the considerations of increased tumor lethal-
ity for highly ionizing radiation. The second term in Eq. (9) is 
increased by a tumor lethality fraction, Flethal . The second term 
in Eq. (9) has been reduced to be independent of the particle 
type, j, using the variable Xtr = Z∗2/β2 as described previously 
(Cucinotta et al., 2013a). For the sensitivity study of Flethal , we 
considered a PDF to represent the uncertainty in the increased 
lethality for HZE particles and secondary charged particles from 
neutrons. The PDF is modeled as a normal distribution considering 
a median value of 1.5 and 25% variance. We note that the RBE val-
ues for solid tumors considered previously (Cucinotta et al., 2013a;
Cucinotta, 2015) were for tumor incidence and the sensitivity 
study of Eq. (9) is not used for leukemia risk estimates because 
there is no evidence for increased high LET mortality compared to 
low LET from mouse studies.
For the various parameters that enter into the model PDFs 
are formulated based on experimental data to represent plausible 
ranges of values. The most recent report (Cucinotta, 2015) used 
solid tumor data in mice directly to model the value and PDF for 
the parameter Σ0/αγ , where the PDF is represented by a three-
parameter logistic function. Bayesian analysis is used to model the 
uncertainty in the DDREF parameter. The BEIR VII Report estimate 
(BEIR VII, 2006) for the Japanese Life-Span Study (LSS) study of 
DDREF = 1.3 with 95% conﬁdence intervals (CI) of [0.8, 1.9] was 
used as the prior distribution, which is updated using Bayes’ the-
orem with the likelihood function for the RBEs represented by a 
log-normal distribution. The resulting posterior distribution has a 
mean value of 1.88 with 95% CI of [1.18, 3.0]. For the central values 
of REID estimates for space missions discussed below we continue 
to use the value DDREF = 1.5 as recommended by the BEIR VII re-
port and the review of the NSCR-2012 model by the NRC (NRC, 
2012), however the posterior distribution is used to represent the 
PDF for the DDREF uncertainty in the analysis described here.
For summary variables of uncertainties we considered 90% and 
95% conﬁdence intervals as well as the REID predictions of central 
estimate or central estimate plus one standard deviation (SD). In 
addition we considered non-parametric tests for deviation from a 
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panel) and males (lower panel) comparing the older NSCR-2012 to the more recent 
NSCR-2014 predictions.
normal distribution using the Kolmogorov–Smirnov and Anderson–
Darling tests, as well as calculations of the second and third-
moment for evaluation of skewness parameters. However, in each 
case considered the distributions failed tests for normal distribu-
tions, and were found to be highly skewed as also observed by 
visual inspection of the overall PDF for REID predictions.
3. Results
We ﬁrst considered risk predictions for annual GCR exposures 
during the time of a deep solar minimum represented by the 2009 
environment (Cucinotta et al., 2013a). For all calculations we con-
sidered 45-y never-smoker (NS) male or female astronauts, and 
assumed an average spacecraft shielding amount of 20 g/cm2 of 
aluminum. Predictions of REID for other shielding materials and 
amounts, and for other ages at exposure were considered previ-
ously for the NSCR-2012 model (Cucinotta et al., 2013a). Fig. 1
shows the predictions for the overall PDF for the REID from cancer 
alone in the NSCR-2012 and NSCR-2014 models. NSCR-2014 shows 
a considerable reduction in the central value of REID and the up-
per conﬁdence levels compared to NSCR-2012 of about 25% and 
35%, respectively due to its use of the revised QF model where 
space radiation risks are scaled to acute γ -ray data. REID predic-
tions are then used to estimate the number of “safe days” outside 
of low Earth orbit under different assumptions of allowable un-Fig. 2. Predictions of the number of “safe days” in space to be below career exposure 
limits for REID using different assumptions on allowable uncertainties. Comparisons 
are for 45-y male and female never smokers in NSCR-2012 and 2014 models.
certainty for female and male NS populations (Fig. 2). Here “safe 
days” are predicted for the central estimate, while including un-
certainties at the 1-Sigma, or the uncertainties at the upper 90% 
or upper 95% conﬁdence intervals. Difference between these met-
rics of uncertainties is reduced in comparison to those that would 
result for a normal distribution due to the highly skewed PDFs that 
occur. A Mars mission would require about 400 days in deep space 
to transit to Mars and return, while longer times of ∼500 days 
on the Mars surface occur albeit with much lower radiation expo-
sure due to the Martian solid body, atmosphere, and possibility of 
in-situ radiation shielding. Our results show that if a smaller un-
certainty was achieved transit mission times exceeding 400 days 
could be achieved for both male and female astronauts.
We next considered how REID predictions could be altered by 
the addition of circulatory disease risk using a meta-analysis of 
several human populations exposed to low LET radiation. Also we 
considered our recent method to estimate the inﬂuence of in-
creased tumor lethality from high LET radiation as suggested by 
most studies in mice of HZE particle tumor induction. Fig. 3 shows 
predictions of the PDF versus REID for fatal cancer alone or with 
these additional risks for the 2009 GCR environment. The circu-
latory disease risk increased REID values by about 70% and 40% 
for males and females, respectively, while the estimate of a higher 
lethality for high LET induced tumors increased REID estimates by 
about 20% with a larger impact on the upper conﬁdence intervals 
because of its impact on increasing the skewness of the distribu-
tion. Fig. 4 shows the impact of these additions on the number 
of “safe days” where large reductions in “safe days” are observed 
with these additional risk components.
The 2009 GCR environment is somewhat deeper meaning less 
solar modulation or higher particle ﬂuxes at low to moderate par-
ticle energies. We next made comparisons to the average annual 
GCR exposure using a solar modulation parameter of 580 MV de-
rived from sunspot number data from the 18th century through 
2012 in our earlier report (Cucinotta et al., 2013a), which compares 
with the value of 420 MV for the 2009 solar minimum. Table 2
shows the predictions of %REID for different assumptions in the 
NSCR-2014 model. Fig. 5 compares the predictions for safe days for 
the deep 2009 solar minimum case to predictions for the average 
GCR environment. The results of Fig. 5 show that if uncertainties 
were reduced by about two-fold from current values the number 
of safe days would approach required trip times for the worse case 
of a deep solar minimum, while Mars missions for average solar 
cycle conditions are nearly obtainable if adequate solar particle 
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addition of circulatory disease risks and increased fatality from high LET particles 
for females (upper panel) and males (lower panel).
event shielding and alert instrumentation and dosimetry are uti-
lized. Solar minimum is not expected to last more than 1-year and 
considering the Mars surface times needed, it is highly unlikely 
that crew would be exposed to the worse-case GCR on both seg-
ments of the Mars transit from Earth and back. These comparisons 
also demonstrate clearly that the uncertainties in REID predictions 
are the over-arching issue and have a much larger impact com-
pared to solar cycle and shielding.
4. Discussion
Major consideration for mission planners for future exploration 
missions to Mars and other destinations is to consider long-term 
GCR exposures outside the protection of Earth’s magnetosphere 
and solid body. NASA follows radiation limits which allow for a 
risk probability of no more than 3% cancer fatality. In recent years 
substantial efforts in spaceﬂight safety have reduced overall prob-
abilities of loss of crew (LOC) to about 1 in 270 with expectations 
of achieving a 1 in 750 probability with near-term investments 
(Aerospace Safety Advisory Panel, 2010). Therefore it will be diﬃ-
cult to argue for a larger acceptable radiation risk than the current 
1 in 33 cancer fatality limit when such large reductions in ﬂight 
safety were achieved in other spaceﬂight safety areas. Previous 
arguments (Cucinotta et al., 2013b) suggest a 10 to 1 ratio of radi-
ation to LOC risk may be appropriate after adjustment for years of 
life-loss from radiation cancers estimates at 20 years for a 45-y age 
at exposure compared to ﬂight failure of about 35 years for an 80 
year life expectancy. Therefore it is of continued interest to reduce Fig. 4. Predictions of the number of “safe days” in space to be below career exposure 
limits for REID using different assumptions on allowable uncertainties in the NSCR-
2014 model without or with additional fatal risk contributors. Comparisons are for 
45-y male and female never smokers in the NSCR-2012 and NSCR-2014 models.
uncertainties in GCR risk predictions and focus research efforts on 
the discovery of new approaches to mitigate their effects.
In this paper we have shown how alternative REID prediction 
methods could impact allowable mission lengths. It is clear that if 
central estimates are not modiﬁed greatly in the future or reduced, 
while concomitant reduction in uncertainties occurred due to ra-
diobiology research ﬁndings, then radiation safety factors could be 
achieved to support such missions with acceptable risks. The re-
duction in cancer risk estimates found in the NSCR-2014 model 
compared to the earlier NSCR-2012 model is larger than several 
possible mission design alternatives, such as doubling the shield-
ing mass or using hydrogenous shielding materials. Either of these 
approaches would reduce REID values by only about 10% and only 
after a high ﬁnancial cost (Cucinotta et al., 2013a). Because mission 
managers must consider cost-beneﬁt analysis within the context of 
risk assessment models, this example highlights the much higher 
importance that should be placed on gaining the radiobiology data 
and knowledge required to improve models of risk compared to 
research on computer codes of particle transport, shielding perfor-
mance, and space environments. The later are of suﬃcient accuracy 
at this time as noted by the National Research Council (NRC, 2012).
However the addition of circulatory disease risks, the poten-
tial for CNS effects during or post-mission (Cucinotta et al., 2014;
Cherry et al., 2012), and qualitative differences in cancers in-
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Predictions under different assumptions of the %REID (mean values), and 90% or 95% conﬁdence intervals for annual GCR exposure in deep space with 20 g/cm2 aluminum 
shielding. Predictions shown are for 45-y Female or Male never-smokers for the 2009 GCR environment and the average annual GCR exposure over many solar cycles.
%REID 90% CI 95% CI REID 90% CI 95% CI
Females Average GCR environment Females 2009 GCR environment
Cancer 1.16 [0.37,2.83] [0.27,3.7] 1.54 [0.5,3.74] [0.37,4.76]
Cancer + Circulatory 1.69 [0.81,3.41] [0.69,4.23] 2.25 [1.07,4.53] [0.93,5.58]
Cancer with increased 
high LET lethality
1.42 [0.53,5.25] [0.39,6.63] 1.89 [0.72,6.67] [0.53,8.45]
Cancer with increased 
high LET lethality +
Circulatory
1.95 [0.99,5.77] [0.81,7.34] 2.6 [1.33,7.54] [1.1,9.51]
Males Average GCR environment Males 2009 GCR environment
Cancer 0.88 [0.34,2.09] [0.28,2.69] 1.18 [0.45,2.83] [0.38,3.61]
Cancer + Circulatory 1.53 [0.85,2.85] [0.77,3.41] 2.04 [1.13,3.81] [1.0,4.59]
Cancer with increased 
high LET lethality
1.09 [0.46,3.81] [0.39,5.04] 1.45 [0.62,5.0] [0.52,6.47]
Cancer with increased 
high LET lethality +
Circulatory
1.73 [1.01,4.51] [0.9,5.81] 2.31 [1.34,5.94] [1.19,7.46]Fig. 5. Predictions of the number of “safe days” in space to be below career expo-
sure limits for REID in the NSCR-2014 model from the 2009 GCR and the average 
annual GCR over all solar cycles. Comparisons for 45-y female (upper panel) and 
male (lower panel) never smokers are made for cancer alone or total REID, which 
includes cancer with increased high LET lethality and circulatory diseases.
duced by high LET radiation are over-arching issues that could 
work against a conclusion of lower risk estimates in the future. 
The NCRP recently reviewed the risks of circulatory disease (NRC, 
2012) and noted that the human epidemiology data suffers from 
unexplained variability between studies and imprecise dosime-
try, while very little experimental data with animals, especially 
at space relevant doses have been reported. For astronauts the 
healthy worker effect in standard mortality rates seen in our pre-
vious analysis (Cucinotta et al., 2013a) is largely driven by the 
signiﬁcantly lower circulatory disease risk observed compared to 
the average U.S. population and could impact radiation sensitivity 
to circulatory risks from space radiation. The importance of us-
ing space relevant doses which corresponds to dose below 0.1 Gy 
of HZE particles (Cucinotta et al., 2014) is crucial for research on 
non-cancer effects since not only are dose thresholds plausible, but 
severity of effect is expected to increase above a dose threshold 
making results at higher doses of little importance for space radio-
biology.
Several recent reviews have noted the importance of NTEs
for high LET radiation. The supra-linear dose responses produced 
by NTEs at low dose can substantially increase RBE estimates 
and skew PDFs for cancer risk estimates (Cucinotta et al., 2013a;
Barcellos-Hoff and Nyugen, 2009; Kadhim et al., 2013; Cucinotta 
and Chappell, 2010). Calculations for the mixed-ﬁeld GCR envi-
ronment are under development, however, our earlier calculations 
for single particle species show signiﬁcant skewness in PDFs for 
REID predictions will occur if NTEs are modeled in conjunction 
with the nominal linear dose response model used for HZE par-
ticles (Cucinotta et al., 2013a).
The NSCR-2014 model enjoys a signiﬁcant reduction in over-
all uncertainty compared to our previous NSCR-2012 model due 
to an improved treatment of the QF and DDREF and their possi-
ble correlations (Cucinotta, 2015). Estimates of maximum relative 
biological effectiveness (RBEmax) deﬁned by the ratio of initial lin-
ear slopes determined at low dose and dose-rate for particles to 
γ -rays are used in radiation protection to assign values of QFs. 
Values of RBEmax are highly dependent on the reference radiation 
used and their responses at low dose and dose-rates. The large 
values of RBEmax found in many experiments can be attributed in-
part to the ineffectiveness of low doses or low dose-rates of γ -rays 
(Cucinotta, 2015). In addition, not all experiments have used ei-
ther low dose-rates (<0.1 Gy/h) or low doses (<0.25 Gy) of γ -rays 
thus precluding RBEmax estimates. We have shown that using RBE’s 
based on acute γ -ray exposures reduced uncertainties and focused 
new research studies on understanding dose-rate effects with pro-
tons and other low LET space components.
F.A. Cucinotta et al. / Life Sciences in Space Research 5 (2015) 31–38 37Table 3
Summary of qualitative differences in tumor response for HZE particles compared to γ -rays or control tumors in mice.
Tumor model Qualitative difference observed
Harderian Gland Tumors in B6CF1 female mice 
(Alpen et al., 1993)
Dose response for Fe particles was qualitatively different from γ -rays. γ -rays required promotion with pituitary 
isografts, while Fe particle dose response showed no signiﬁcant difference with or without isografts.
Hepatocellular carcinoma in male C3H/HeNCrl 
mice (Weil et al., 2014)
Dose response for Si and Fe particles was qualitatively different from γ -rays. Incidence of metastatic tumors 
signiﬁcantly increased with Si and Fe particles compared to γ -rays or simulated solar protons.
Lung tumor in C57BL/6 mice (Wang et al., 
2015)
More aggressive lung tumors observed for Si particles compared to low LET or control tumors.
Mammary tumors in SD rats (Imaoka et al., 
2007) or transgenic mice (Illa-Bochaca et al., 
2014)
Differences in mammary tumor types comparing heavy ions to low LET radiation with more aggressive tumors 
observed.
Intestinal tumors in APCMin/+ mice (Trani et al., 
2010, Datta et al., 2013)
Heavy ions increased tumor multiplicity and grade compared to protons or γ -rays.Several reports (Fry et al., 1985; Alpen et al., 1993; Dicello et 
al., 2004; Weil et al., 2009, 2014; Grahn et al., 1992; Imaoka et al., 
2007; Trani et al., 2010; Datta et al., 2013; Illa-Bochaca et al., 2014;
Wang et al., 2015) have suggested that HZE particles and neutrons 
could produce more lethal tumors compared to tumors produced 
by low LET radiation or background tumors, which is a qualita-
tive difference not accounted for in current risk estimates. Table 3
summarizes these ﬁndings from animal studies with HZE particle 
beams. For low LET radiation there is an implicit assumption made 
by epidemiology models that the tumors induced by radiation are 
similar to background tumors in a population. This assumption is 
consistent with the multiplicative risk model, and also based on 
lack of information to make an alternative assumption. Using the 
sensitivity analysis method described in a recent report (Cucinotta, 
2014, 2015) suggests that increases in tumor lethality for HZE par-
ticle and neutrons compared to background or low LET tumors 
as suggested by animal studies could substantially increase REID 
and uncertainty estimates. In the current paper we have shown 
that the number of “safe days” in space is substantially reduced 
independent of which method is used to address risk prediction 
uncertainty.
5. Conclusions
In conclusion we recommend that uncertainty analysis should 
continue to consider the upper 95% conﬁdence levels in risk pre-
dictions as a safety factor. Current estimates for missions at av-
erage solar cycle conditions suggest central estimates of safe days 
in space exceed 900 and 1200 days, while upper 95% conﬁdence 
levels are less than 300 or 400 days for females and males, respec-
tively. In the future after important information and data bases on 
risks from experimental studies are achieved, testing for normality 
for the PDF of risk estimates should become part of risk analysis. It 
is only when the overall PDF for REID estimates approaches a nor-
mal distribution can safety factors be assured. Highly skewed PDFs
reﬂect underlying mechanisms that could signiﬁcantly alter risk es-
timates if knowledge of their validity is obtained. We fully expect 
that a normal distribution would result from obtaining signiﬁcant 
knowledge and data in the areas of dose-rate and radiation quality 
dependences of risk, NTEs, tumor lethality, and non-cancer effects. 
These possible changes to central REID values could lead to ei-
ther increases or decreases in REID estimates, however conclusive 
knowledge of their impacts would narrow the PDFs for the vari-
ous factors that enter into risk models, such as risk coeﬃcients for 
cancer and non-cancer mortality, QFs, DDREFs, etc. Therefore this 
knowledge would reduce the skewness in current uncertainty esti-
mates. Because REID projections could increase by several times 
that of the current central REID estimate, it is crucial that this 
knowledge be obtained. At a future time when a normal distribu-
tion of uncertainty is achieved, the space radiation strategic goal of a 50% overall uncertainty (Strategic, 1998) can be used as practical 
measure for spaceﬂight safety programs.
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